Sangamo Therapeutics Received U.S. FDA Fast Track Designation for ST-503 for the Treatment of Small Fiber Neuropathy

Click here to view

Presentation

Genome Orthogonal Zinc Finger Proteins for the Development of Genomic Medicines

Download PDF